Clinically, analysis of a cohort containing hepatitis B virus-infected HCC patients (GSE14520) and data from The Cancer Genome Atlas showed that elevated STAT6 expression is a prognostic biomarker for HCC (Wang X. et al., 2019). This evidence concerns the gene STAT6 and hepatocellular carcinoma.